Tocotrienols in Parkinson's Disease (PD)
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Neuro-Degenerative Disease
- Parkinson Disease
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Experimental (Tocovid Suprabio (HOV-12020)) vs Control (Placebo)Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: This is a double-blind clinical trial.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 50 years and 90 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04491383
- Collaborators
- Hovid Berhad
- Investigators
- Principal Investigator: Eng King Tan National Neuroscience Institute Singapore Principal Investigator: Adeline Su-Lyn Ng National Neuroscience Institute Singapore
Get Well Soon